Sign up to receive

Real-time alerts & small-cap investment opportunities

Business

business newspaper read by man

Radiant Logistics Rebrands Brokerage Platform to Radiant Road & Rail Services

Business Headlines What's Hot

Radiant Logistics, Inc. (NYSE: RLGT) reported Friday the rebranding of its U.S. brokerage platform, the Clipper Exxpress Company (d/b/a Radiant Clipper), to Radiant Road & Rail Services....

NIO car wash

NIO EV Manufacturer Delivered Almost 13000 Vehicles in June

Breaking Business Technology What's Hot

Nio (NYSE: NIO), a Chinese EV manufacturer, delivered almost 13,000 vehicles in June, a 60% increase from the...

Advertisement

What are you waiting for?

Sign up to become a MarketDepth Insider today!

Sign up today

Contract signature pen

Bed Bath & Beyond Appoints Chief Accounting Officer and Head of Treasury

Business Headlines Lifestyle What's Hot

Bed Bath & Beyond Inc. (NASDAQ: BBBY) has announced Laura Crossen as Senior Vice President of Finance and...

Advertisement

What are you waiting for?

Sign up to become a MarketDepth Insider today!

Sign up today

Clarity Gold Portfolio Banner

Investing

Cancer Research

NeuroSense Reports Positive Preliminary Results from Alzheimer’s Biomarker Study

Biotechnology Headlines Healthcare Investing What's Hot

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) has reported results from its biomarker study conducted to evaluate the potential CogniC, NeuroSense’s drug for treatment of Alzheimer’s disease....

Meeting in front of windows black and white

Hillstream BioPharma Partners with Sapien Biosciences

Biotechnology Breaking Healthcare Investing What's Hot

Hillstream BioPharma, Inc. (Nasdaq: HILS) today announced that it has begun a collaboration with Sapien Biosciences to evaluate...

Cancer Research microscope test tubes

F-star Therapeutics to be Acquired by invoX Pharma for USD 7.12 Per Share

Biotechnology Headlines Healthcare Investing What's Hot

F-star Therapeutics, Inc. (NASDAQ: FSTX) has announced that invoX Pharma, subsidiary of Sino Biopharm has plans to acquire...